Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Advertisement

British Journal of Cancer
  • View all journals
  • Search
  • My Account Login
  • Content Explore content
  • About the journal
  • Publish with us
  • Sign up for alerts
  • RSS feed
  1. nature
  2. british journal of cancer
  3. regular article
  4. article
The ability to accumulate deoxyuridine triphosphate and cellular response to thymidylate synthase (TS) inhibition
Download PDF
Download PDF
  • Regular Article
  • Open access
  • Published: 31 July 2001

The ability to accumulate deoxyuridine triphosphate and cellular response to thymidylate synthase (TS) inhibition

  • S D Webley1,
  • S J Welsh1,
  • A L Jackman1 &
  • …
  • G W Aherne1 

British Journal of Cancer volume 85, pages 446–452 (2001)Cite this article

  • 1371 Accesses

  • 43 Citations

  • Metrics details

This article has been updated

Abstract

Thymidylate synthase (TS) is an important enzyme catalysing the reductive methylation of dUMP to dTMP that is further metabolized to dTTP for DNA synthesis. Loss of viability following TS inhibition occurs as a consequence of depleted dTTP pools and at least in some cell lines, accumulation of dUTP and subsequent misincorporation of uracil into DNA. The expansion in dUTP pools is largely determined by the expression of the pyrophosphatase, dUTPase. Our previous work has shown that following TS inhibition the ability to accumulate dUTP was associated with an earlier growth inhibitory effect. 3 human lung tumour cell lines and HT29 human colon tumour cells transfected with dUTPase have been used to investigate the relationship between loss of viability following TS inhibition and dUTP accumulation. Cell cycle arrest typical of TS inhibition was an early event in all cell lines and occurred irrespective of the ability to accumulate dUTP or p53 function. However, a large expansion of dUTP pools was associated with mature DNA damage (4 h) and an earlier loss of viability following TS inhibition compared to cells in which dUTP pools were not expanded. In A549 cells damage to mature DNA may have been exacerbated by significantly higher activity of the excision repair enzyme, uracil-DNA glycosylase. Consistent with results using different inhibitors of TS, transfection of dUTPase into HT29 cells significantly reduced the cytotoxicity of a 24 h but not 48 h exposure to ZD9331. Although loss of viability can be mediated through dTTP deprivation alone, the uracil misincorporation pathway resulted in an earlier commitment to cell death. The relevance of this latter pathway in the clinical response to TS inhibitors deserves further investigation. © 2001 Cancer Research Campaign

Similar content being viewed by others

Targeting nucleotide metabolism enhances the efficacy of anthracyclines and anti-metabolites in triple-negative breast cancer

Article Open access 06 April 2021

Structural dynamics of human deoxyuridine 5’-triphosphate nucleotidohydrolase (dUTPase)

Article Open access 30 October 2024

Bacteriophage-related epigenetic natural and non-natural pyrimidine nucleotides and their influence on transcription with T7 RNA polymerase

Article Open access 09 November 2024

Article PDF

Change history

  • 16 November 2011

    This paper was modified 12 months after initial publication to switch to Creative Commons licence terms, as noted at publication

References

  • Aherne GW, Hardcastle A, Raynaud F and Jackman AL (1996) Immunoreactive dUMP and TTP pools as an index of thymidylate synthase inhibition; Effect of Tomudex (ZD1694) and a nonpolyglutamated quinazoline antifolate (CB30900) in L1210 mouse leukaemia cells. Biochem Pharmacol 51: 1293–1301

    Article  CAS  PubMed  Google Scholar 

  • Aherne GW and Brown SD (1999) The role of uracil misincorporation in thymineless death. Anticancer Drug Development Guide: Antifolate Drugs in Cancer Therapy, AL Jackman (ed) Humana Press Inc.: Totowa, NJ 409–421

    Chapter  Google Scholar 

  • Arrendondo MA, Yin MB, Lu K, Schoeber C, Slocum HK and Rustum YM (1994) Decreased c-myc protein accompanied by increased p53 and Rb is associated with thymidylate synthase inhibition and cell cycle retardation induced by ZD1694. Proc Am Assoc Cancer Res 35: 304

    Google Scholar 

  • Brown SD, Hardcastle A and Aherne GW (1997) Deoxyuridine triphosphatase (dUTPase) expression and cellular response to TS inhibitors. Chemistry and Biology of Pteridines and Folates, Pfleider W, Rokos H (eds) pp. 271–274 Blackwell Science: Berlin

    Google Scholar 

  • Brynolf K, Eliasson R and Reichard P (1978) Formation of Okazaki fragments in polyoma DNA synthesis caused by misincorporation of uracil. Cell 13: 573–580

    Article  CAS  PubMed  Google Scholar 

  • Canman CE, Lawrence TS, Shewach DS, Tang HY and Maybaum J (1993) Resistance to fluorodeoxyuridine induced DNA damage and cytotoxicity correlates with an elevation of deoxyuridine triphosphatase activity and failure to accumulate deoxyuridine triphosphate. Cancer Res 53: 1–6

    Google Scholar 

  • Canman CE, Radany EH, Parsels LA, Davis MA, Lawrence TS and Maybaum J (1994) Induction of resistance to fluorodeoxyuridine cytotoxicity and DNA damage in human tumour cells by expression of Escherichia-coli deoxyuridine triphosphatase. Cancer Res 54: 2296–2298

    CAS  PubMed  Google Scholar 

  • Caradonna SJ and Cheng Y (1980) Uracil DNA-glycosylase: purification and properties of this enzyme isolated from blast cells of acute myelocytic leukemia patients. J Biol Chem 255: 2293–2300

    CAS  PubMed  Google Scholar 

  • Chong L and Tattersall MHN (1995) 5, 10 Dideazatetrahydrofolic acid reduces toxicity and deoyadenosine triphosphate pool expansion in cultural L1210 cells treated with inhibitors of thymidylate synthase. Biochem Pharmacol 49: 819–827

    Article  CAS  PubMed  Google Scholar 

  • Curtin NJ, Harris AL and Aherne GW (1991) Mechanisms of cell death following thymidylate synthase inhibition: 2 deoxyuridine 5 triphosphate accumulation, DNA damage, and growth inhibition following exposure to CB3717 and dipyridamole. Cancer Res 51: 2346–2352

    CAS  PubMed  Google Scholar 

  • Darzynkiewicz Z, Bruno S, Del Bino G, Gorczyca W, Hotz MA, Lassota P and Traganos F (1992) Features of apoptotic cells measured by flow cytometry. Cytometry 13: 795–808

    Article  CAS  PubMed  Google Scholar 

  • Fisher TC, Milner AE, Gregory CD, Jackman AL, Aherne GW, Hartley JA, Dive C and Hickman J (1993) Bcl-2 modulation of apoptosis induced by anticancer drugs-resistance to thymidylate stress is independent of classical resistance pathways. Cancer Res 53: 3321–3326

    CAS  PubMed  Google Scholar 

  • Goulian M, Bleile BM, Dickey LM, Grafstrom RH, Ingraham HA, Neynaben SA, Peterson MS and Tseng BY (1986) Mechanism of thymineless death. Adv Exp Med Biol 195: 89–95

    Article  PubMed  Google Scholar 

  • Hartwell L and Kastan MB (1994) Cell cycle control and cancer. Science (Washington DC) 266: 1821–1828

    Article  CAS  Google Scholar 

  • Houghton JA, Harwood FG and Houghton PS (1994) Cell cycle control processes determine cytostasis or cytotoxicity in thymineless death of colon cancer cells. Cancer Res 54: 4967–4973

    CAS  PubMed  Google Scholar 

  • Houghton JA, Tilman DM and Harwood FG (1995) Ratio of 2′-deoxyadenosine-5′-triphosphate/ thymidine-5′-triphosphate influences the commitment of human colon carcinoma cells to thymineless death. Clin Cancer Res 1: 723–730

    CAS  PubMed  Google Scholar 

  • Jackman AL and Judson IR (1996) The new generation of thymidylate synthase inhibitors in clinical study. Exp Opin Invest Drugs 5: 719–736

    Article  CAS  Google Scholar 

  • Jackman AL, Kimbell R, Aherne GW, Brunton L, Jansen G, Stephens TC, Smith MC, Wardleworth JM and Boyle FT (1997) Cellular pharmacology and invivo activity of a new anticancer agent ZD9331: A water-soluble, nonpolyglutamatable, quinazoline inhibitor of thymidylate synthase. Clin Cancer Res 3: 911–921

    CAS  PubMed  Google Scholar 

  • Jackson RC, Jackman AL and Calvert AH (1983) Biochemical effects of quinazoline inhibitor of thymidylate synthase CB3717 on human lymphoblastoid cells. Biochem Pharmocol 33: 3783–3790

    Article  Google Scholar 

  • Kohn KW (1981) Principles and practice of DNA filter elution. Pharmac Ther 49: 55–77

    Article  Google Scholar 

  • Ladner R and Caradonna S (1997) Lowering dUTPase levels through antisense induces sensitivity to fluorodeoxyuridine in HT29 cells. Proc Am Assoc Cancer Res 38: 614

    Google Scholar 

  • Matsui S, Arredondo MA, Wrzosek C and Rustum YM (1996) DNA damage and p53 induction do not cause ZD1694-induced cell cycle arrest in human colon carcinoma cells. Cancer Res 56: 4715–1723

  • Muller-Weeks S and Caradonna S (1996) Specific association of cyclin like uracil-DNA glycosylase with the proliferating cell nuclear antigen. Exp Cell Res 226: 346–355

    Article  CAS  PubMed  Google Scholar 

  • Nelson WG and Kastan MB (1994) DNA strand breaks: the DNA template alterations that trigger p53-dependent DNA damage response pathways. Mol Cell Biol 14: 1815–1823

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • O'Connor PM (1987) Mammalian G1 and G2 phase checkpoints. Cancer Surv 29: 151–182

    Google Scholar 

  • Parsels LA, Parsels JD, Wagner LM, Loney TL, Radany EH and Maybaum J (1998) Mechanism and pharmacological specificity of dUTPase-mediated protection from DNA damage and cytotoxicity in human tumor cells. Cancer Chemother Pharmacol 42: 357–362

    Article  CAS  PubMed  Google Scholar 

  • Savage JRK and Prasad R (1988) Generalized blocking in S phase by methotrexate. Mut Res 201: 195–201

    Article  CAS  Google Scholar 

  • Skelton LA, Ormerod MG, Titley JC and Jackman AL (1998) Cell cycle effects of CB30865, a lipophilic quinazoline-based analogue ICI 198583 with an undefined mechanism of action. Cytometry 33: 56–66

    Article  CAS  PubMed  Google Scholar 

  • Sundseth R, Singer S, Yates B, Smith G, Ferone R and Dev I (1997) Thymineless apoptotic death induced by 1843U89 in human tumour cell lines is independent of dUTP accumulation and misincorporation of dUMP into DNA. Proc Am Assoc Cancer Res 38: 476

    Google Scholar 

  • Tang HY, Weber KL, Lawrence TS, Merchant AK and Maybaum J (1996) Dependence of fluorodeoxyuridine-induced cytotoxicity and megabase DNA fragmentation on S phase progression in HT29 cells. Cancer Chemother Pharmacol 37: 486–490

    Article  CAS  PubMed  Google Scholar 

  • Taylor IW, Slowiaczek P, Francis PR and Tattersall MHN (1982) Purine modulation of methotrexate cytotoxicity in mammalian cell lines. Cancer Res 42: 5159–5164

    CAS  PubMed  Google Scholar 

  • Tonkinson JL, Marder P, Andis SL, Schultz RM, Gossett LS, Shih C and Mendelsohn LG (1997) Cell cycle effects of antifolate antimetabolites: implications for cytotoxicity and cytotasis. Cancer Chemother Pharmacol 39: 521–531

    Article  CAS  PubMed  Google Scholar 

  • Webley SD, Hardcastle A, Ladner RD, Jackman AL and Aherne GW (2000) Deoxyuridine triphosphate (dUTPase) expression and sensitivity to the thymidylate synthase (TS) inhibitor ZD9331. Br J Cancer 83: 792–799

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Yin MB, Guimalaes MA, Zhang Z, Arrendondo MA and Rustum YM (1992) Time dependence of DNA lesions and growth inhibition by ICI D1694, a new quinazoline antifolate thymidylate synthase inhibitor. Cancer Res 52: 5900–5905

    CAS  PubMed  Google Scholar 

  • Zambetti GP and Levine AJ (1993) A comparison of the biological activities of wild type and mutant p53. FASEB J 7: 855–865

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. CRC Centre for Cancer Therapeutics, Institute of Cancer Research, 15 Cotswold Road, Sutton, SM2 5NG, Surrey

    S D Webley, S J Welsh, A L Jackman & G W Aherne

Authors
  1. S D Webley
    View author publications

    Search author on:PubMed Google Scholar

  2. S J Welsh
    View author publications

    Search author on:PubMed Google Scholar

  3. A L Jackman
    View author publications

    Search author on:PubMed Google Scholar

  4. G W Aherne
    View author publications

    Search author on:PubMed Google Scholar

Rights and permissions

From twelve months after its original publication, this work is licensed under the Creative Commons Attribution-NonCommercial-Share Alike 3.0 Unported License. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/

Reprints and permissions

About this article

Cite this article

Webley, S., Welsh, S., Jackman, A. et al. The ability to accumulate deoxyuridine triphosphate and cellular response to thymidylate synthase (TS) inhibition. Br J Cancer 85, 446–452 (2001). https://doi.org/10.1054/bjoc.2001.1921

Download citation

  • Received: 25 October 2000

  • Revised: 24 April 2001

  • Accepted: 26 April 2001

  • Published: 31 July 2001

  • Issue date: 03 August 2001

  • DOI: https://doi.org/10.1054/bjoc.2001.1921

Share this article

Anyone you share the following link with will be able to read this content:

Sorry, a shareable link is not currently available for this article.

Provided by the Springer Nature SharedIt content-sharing initiative

Keywords

  • dUTPase
  • thymidylate synthase
  • ZD9331
  • dUTP
  • uracil misincorporation

This article is cited by

  • Discovery of two new isoforms of the human DUT gene

    • Gergely Attila Rácz
    • Nikolett Nagy
    • Beáta G. Vértessy

    Scientific Reports (2023)

  • Metabolic basis of neuronal vulnerability to ischemia; an in vivo untargeted metabolomics approach

    • Sherif Rashad
    • Daisuke Saigusa
    • Teiji Tominaga

    Scientific Reports (2020)

  • Structural model of human dUTPase in complex with a novel proteinaceous inhibitor

    • Kinga Nyíri
    • Haydyn D. T. Mertens
    • Beáta G. Vértessy

    Scientific Reports (2018)

  • Standing the test of time: targeting thymidylate biosynthesis in cancer therapy

    • Peter M. Wilson
    • Peter V. Danenberg
    • Robert D. Ladner

    Nature Reviews Clinical Oncology (2014)

  • Mechanism of trifluorothymidine potentiation of oxaliplatin-induced cytotoxicity to colorectal cancer cells

    • O H Temmink
    • E K Hoebe
    • G J Peters

    British Journal of Cancer (2007)

Download PDF

Advertisement

Explore content

  • Research articles
  • Reviews & Analysis
  • News & Comment
  • Current issue
  • Collections
  • Follow us on Twitter
  • Sign up for alerts
  • RSS feed

About the journal

  • Journal Information
  • Open access publishing
  • About the Editors
  • Contact
  • Special Issues
  • For Advertisers
  • Subscribe

Publish with us

  • For Authors & Referees
  • Language editing services
  • Submit manuscript

Search

Advanced search

Quick links

  • Explore articles by subject
  • Find a job
  • Guide to authors
  • Editorial policies

British Journal of Cancer (Br J Cancer)

ISSN 1532-1827 (online)

ISSN 0007-0920 (print)

nature.com sitemap

About Nature Portfolio

  • About us
  • Press releases
  • Press office
  • Contact us

Discover content

  • Journals A-Z
  • Articles by subject
  • protocols.io
  • Nature Index

Publishing policies

  • Nature portfolio policies
  • Open access

Author & Researcher services

  • Reprints & permissions
  • Research data
  • Language editing
  • Scientific editing
  • Nature Masterclasses
  • Research Solutions

Libraries & institutions

  • Librarian service & tools
  • Librarian portal
  • Open research
  • Recommend to library

Advertising & partnerships

  • Advertising
  • Partnerships & Services
  • Media kits
  • Branded content

Professional development

  • Nature Awards
  • Nature Careers
  • Nature Conferences

Regional websites

  • Nature Africa
  • Nature China
  • Nature India
  • Nature Japan
  • Nature Middle East
  • Privacy Policy
  • Use of cookies
  • Legal notice
  • Accessibility statement
  • Terms & Conditions
  • Your US state privacy rights
Springer Nature

© 2025 Springer Nature Limited